PS-2747: a new antidepressant agent.
D000284:Administration, Oral; D000480:Alkynes / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D001362:Avoidance Learning / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D002934:Cinnamates / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D004597:Electroshock; D004987:Ethers / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005071:Evoked Potentials / Q000187:drug effects; D000882:Haplorhini; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D014149:Tranquilizing Agents / Q000494:pharmacology
D000480:Alkynes; D000588:Amines; D000927:Anticonvulsants; D000928:Antidepressive Agents; D002934:Cinnamates; D004987:Ethers; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D000639:Amitriptyline; D004295:Dihydroxyphenylalanine; D010293:Pargyline